Movement Alert｜BeiGene Falls 3.1% in Regular Trading, Major Shareholder Reduction and Biotech Sector Weakness Weigh on Shares

Market Focus06-05

On June 5, BeiGene fell 3.1% in regular trading, trading at HKD 162.6/share, with trading volume of HKD 550 million. The decline marks the stock's continued slide this week, pressured by both company-specific and sector-wide headwinds.

On the news front, Baker Bros. Advisors LP, a major shareholder affiliated with board members, recently reduced its position by approximately USD 190 million. While the fund retains its board seat and still holds around 8.21% of shares, the sizable reduction has persistently weighed on market sentiment. Additionally, the Hong Kong-listed innovative drug sector has been in a correction for over eight months since last September, with the sector benchmark index declining more than 30% over that period.

Within the Biotechnology sector, the overall tone remained weak. Among peers, AKESO fell 4.17%, REMEGEN fell 2.56%, 3SBIO fell 1.94%, and INNOVENT BIO fell 0.2%, while SKB BIO edged up 0.21%. As a heavyweight leader in the sector, BeiGene continues to be dragged by broad-based selling pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1158128478?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-05 13:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1158128478","market":"hk","top_or_hot":-1,"title":"Movement Alert｜BeiGene Falls 3.1% in Regular Trading, Major Shareholder Reduction and Biotech Sector Weakness Weigh on Shares","media":"Market Focus","content":"<p><p>On June 5, BeiGene fell 3.1% in regular trading, trading at HKD 162.6/share, with trading volume of HKD 550 million. The decline marks the stock's continued slide this week, pressured by both company-specific and sector-wide headwinds.</p><p>On the news front, Baker Bros. Advisors LP, a major shareholder affiliated with board members, recently reduced its position by approximately USD 190 million. While the fund retains its board seat and still holds around 8.21% of shares, the sizable reduction has persistently weighed on market sentiment. Additionally, the Hong Kong-listed innovative drug sector has been in a correction for over eight months since last September, with the sector benchmark index declining more than 30% over that period.</p><p>Within the Biotechnology sector, the overall tone remained weak. Among peers, AKESO fell 4.17%, REMEGEN fell 2.56%, 3SBIO fell 1.94%, and INNOVENT BIO fell 0.2%, while SKB BIO edged up 0.21%. As a heavyweight leader in the sector, BeiGene continues to be dragged by broad-based selling pressure.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜BeiGene Falls 3.1% in Regular Trading, Major Shareholder Reduction and Biotech Sector Weakness Weigh on Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜BeiGene Falls 3.1% in Regular Trading, Major Shareholder Reduction and Biotech Sector Weakness Weigh on Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-05 13:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 5, BeiGene fell 3.1% in regular trading, trading at HKD 162.6/share, with trading volume of HKD 550 million. The decline marks the stock's continued slide this week, pressured by both company-specific and sector-wide headwinds.</p><p>On the news front, Baker Bros. Advisors LP, a major shareholder affiliated with board members, recently reduced its position by approximately USD 190 million. While the fund retains its board seat and still holds around 8.21% of shares, the sizable reduction has persistently weighed on market sentiment. Additionally, the Hong Kong-listed innovative drug sector has been in a correction for over eight months since last September, with the sector benchmark index declining more than 30% over that period.</p><p>Within the Biotechnology sector, the overall tone remained weak. Among peers, AKESO fell 4.17%, REMEGEN fell 2.56%, 3SBIO fell 1.94%, and INNOVENT BIO fell 0.2%, while SKB BIO edged up 0.21%. As a heavyweight leader in the sector, BeiGene continues to be dragged by broad-based selling pressure.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1158128478","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1158128478","pubTimestamp":1780637702,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 5, BeiGene fell 3.1% in regular trading, trading at HKD 162.6/share, with trading volume of HKD 550 million. The decline marks the stock's continued slide this week, pressured by both...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"动向提示|百济神州常规交易跌3.1%大股东减持及生物科技板块疲软令股价承压","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"On June 5, BeiGene fell 3.1% in regular trading, trading at HKD 162.6/share, with trading volume of HKD 550 million. The decline marks the stock's continued slide this week, pressured by both company-specific and sector-wide headwinds.On the news front, Baker Bros. Advisors LP, a major shareholder affiliated with board members, recently reduced its position by approximately USD 190 million. While the fund retains its board seat and still holds around 8.21% of shares, the sizable reduction has persistently weighed on market sentiment. Additionally, the Hong Kong-listed innovative drug sector has been in a correction for over eight months since last September, with the sector benchmark index declining more than 30% over that period.Within the Biotechnology sector, the overall tone remained weak. Among peers, AKESO fell 4.17%, REMEGEN fell 2.56%, 3SBIO fell 1.94%, and INNOVENT BIO fell 0.2%, while SKB BIO edged up 0.21%. As a heavyweight leader in the sector, BeiGene continues to be dragged by broad-based selling pressure.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1158128478","isCrawlerRequest":true}